science wire

University of Queensland researchers have designed a device that uses a simple blood test to detect early stage lung cancer.

A chip the size of a pack of cards uses fewer resources and a smaller footprint than existing automated manufacturing platforms and could lead to more affordable cell therapy manufacturing. Researchers from the Singapore-MIT Alliance for Research and Technology (SMART), MIT's research enterprise in Singapore, have developed a novel way to produce clinical doses of viable autologous chimeric antigen receptor (CAR) T-cells in a ultra-small automated closed-system microfluidic chip, roughly the size of a pack of cards.

The Fleming Initiative is calling for designs for its inaugural Centre at St Mary's Hospital.

A new fast test may help identify children missing immunity to tetanus and other essential vaccines.

An extended-release version of buprenorphine, a treatment for opioid use disorder, can be used earlier than other medication.

The close collaboration between the Paul Scherrer Institute PSI and the University Children's Hospital Zurich for the benefit of children suffering from cancer began 20 years ago.

The Centre for Human Drug Research (CHDR) is about to open a new location in Twente. At this location, the Leiden-based drug research institute will work closely with the regional hospital Medisch Spectrum Twente (MST) and University of Twente's Technical Medical Centre (TechMed Centre).

A new artificial intelligence (AI) tool that can help to select the most suitable treatment for cancer patients has been developed by researchers at The Australian National University (ANU).

New approach to diminish antibiotic resistance developed by research team from Freie Universität Berlin, the Hebrew University of Jerusalem, and ETH Zurich Antibiotics are a cornerstone of modern medicine. They are regularly used to treat bacterial infections or as a prophylactic measure during surgery to prevent infection.

Thomas Vogl's research team at MedUni Vienna's Center for Cancer Research aims to identify biomarkers in the gut microbiome that are associated with Long COVID. The "Global Grant for Gut Health", awarded by Yakult and Nature Portfolio, is now supporting them in this endeavour. "If we succeed in finding biomarkers that both indicate a person's risk of Long COVID and represent therapeutic targets against the disease, this could significantly improve our ability to treat and perhaps even prevent Long COVID in the future," says Thomas Vogl, summarising the importance of the research work.

University research expertise combined with Psylo's artificial intelligence platform promises life-changing therapeutics.

Coronary artery disease (CAD) is the most common type of heart disease, impacting  2.6 million Canadians.

Bern, 26. The number of antibiotic-resistant bacteria is on the rise all'over the world. This poses a growing threat to the effective treatment of infections and places a significant burden on health systems, including Switzerland's.

A new artificial intelligence (AI) system that could significantly reduce the time and cost required to recruit clinical trial patients for an advanced form of age-related vision loss has been developed by a team led by UCL and Moorfields Eye Hospital researchers. The system focuses on Geographic Atrophy (GA), an advanced form of dry age-related macular degeneration (AMD) leading to irreversible vision loss and legal blindness.

New data analysis highlights potential "serious consequences" for patient health and lengthy complaint processing times.

The LENS trial has demonstrated that fenofibrate, a drug usually used to lower cholesterol, reduces the risk of progression of diabetic retinopathy by 27%.

Macomics Ltd, a leader in macrophage drug discovery, announces that it has entered a scientific collaboration with Prof. Andrea Alimonti at IOR (Institute of Oncology Research), one of Switzerland's leading research institutes.

Scientists at the University of Cambridge have discovered that a type of white blood cell - called a regulatory T cell - exists as a single large population of cells that constantly move throughout the body looking for, and repairing, damaged tissue. It's difficult to think of a disease, injury or infection that doesn't involve some kind of immune response, and our finding really changes the way we could control this response.

The University of Glasgow, alongside NHS Greater Glasgow & Clyde, has opened the PRIMUS-006 pancreatic cancer study, part of the Precision-Panc Platform.

Leuko, founded by a research team at MIT, is giving doctors a noninvasive way to monitor cancer patients' health during chemotherapy - no blood tests needed. Chemotherapy and other treatments that take down cancer cells can also destroy patients' immune cells. Every year, that leads tens of thousands of cancer patients with weakened immune systems to contract infections that can turn deadly if unmanaged.

Liquid low-calorie or low-carb keto diet can reverse type 2 diabetes, research shows EXPERT Q&A Laura Saslow , associate professor at the University of Michigan School of Nursing, has been researching the impact of different dietary patterns on type 2 diabetes for more than a decade.

Between 2010 and 2020, Quebec doctors became more likely to recommend physical activity for certain diseases but less likely to prescribe it for primary prevention or for obese patients.

Changing the way antibiotics are given to adult patients with sepsis will save thousands of lives a year globally, according to research by The University of Queensland and The George Institute for Global Health.

Few people in the UK with early-stage Alzheimer's disease are likely to be suitable for the latest drugs which aim to halt progress of the condition, yet many are nevertheless likely to be referred for these treatments, finds a new study co-led by UCL researchers.

Johns Hopkins infectious disease specialist Seun Falade-Nwulia works to ensure patients receive the carefully coordinated care they require This article was originally published by Dome in its May/June 2024 issue.

A glowing marker dye that sticks to prostate cancer cells could help surgeons to remove them in real-time, according to a study led by the University of Oxford.

Study: Comprehension and usefulness of Spanish language health information about depression treatment (DOI: 10.1093/her/cyae013) Spanish-language medical information given to Latino/a patients about depression treatment often contains confusing terminology that could decrease comprehension and adherence to treatment recommendations, according to a University of Michigan study.

A new blood test that could identify children with a potentially fatal heart condition has been developed by researchers at UCL and Great Ormond Street Hospital (GOSH).

A new blood test that could identify children with a potentially fatal heart condition has been developed by researchers at UCL and Great Ormond Street Hospital (GOSH).

Cookie policy."},"navigation":{"major":[{"asset_name":"University News","asset_url":"https://news.stanford.edu/university-news","asset_assetid":"141464","children":[{"asset_name":"Distin

Researchers from the University of Oxford will present new exciting data on the R21/Matrix-M malaria vaccine during the 8th Pan-African Malaria Conference, in collaboration with the Ministry of Health (MoH)-Rwanda and the Rwanda Biomedical Centre (RBC).

The Belgian-led consortium consisting of groups from The Queen Astrid Military Hospital (QAMH), KU Leuven and the public health institute Sciensano recently made the cover of Nature Microbiology.

An immunotherapy drug given before surgery instead of chemotherapy meant that significantly more patients with a certain genetic profile were cancer free after surgery, according to clinical trial results presented by researchers at UCL and UCLH.

The Southampton Clinical Trials Unit, based at the University of Southampton, has been chosen to run a new programme accelerating research into potentially ground-breaking cancer treatments.

The founding researchers are experienced in drug discovery and clinical development, and the CEO has a track record in bringing novel therapeutics to market.